(Q37887181)

24 August 2017

1 reference

title

Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease (English)

1 reference

24 August 2017

0 references

0 references

1 reference

Dominique Debray

1

1 reference

24 August 2017

Deirdre Kelly

2

1 reference

24 August 2017

Roderick Houwen

3

1 reference

24 August 2017

Birgitta Strandvik

4

1 reference

24 August 2017

Carla Colombo

5

1 reference

24 August 2017

publication date

1 June 2011

1 reference

Journal of Cystic Fibrosis

24 August 2017

published in

1 reference

24 August 2017

volume

10 Suppl 2

1 reference

24 August 2017

page(s)

S29-36

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

24 August 2017

1 reference

7 January 2021

Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Natural history of liver disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Liver involvement in cystic fibrosis: primary organ damage or innocent bystander?

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Genetic modifiers of liver disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Phosphatidylcholine and lysophosphatidylcholine excretion is increased in children with cystic fibrosis and is associated with plasma homocysteine, S-adenosylhomocysteine, and S-adenosylmethionine

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Non-alcoholic steatohepatitis: from cell biology to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Sclerosing cholangitis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Liver disease and bile duct abnormalities in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Clinical and genetic risk factors for cystic fibrosis-related liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Epidemiology of liver disease in cystic fibrosis: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Cystic fibrosis-associated liver disease: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria?

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Retrospective review of cystic fibrosis presenting as infantile liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Liver disease in children with cystic fibrosis: US-biochemical comparison in 195 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

The role of hepatobiliary scintigraphy in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Normal splenic size in infants and children: sonographic measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Hepatopulmonary syndrome--a liver-induced lung vascular disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Pulmonary vascular abnormalities in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Advanced hepatocellular carcinoma associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Partial splenectomy for portal hypertension in cystic fibrosis related liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Outcome of total splenectomy with portosystemic shunt for massive splenomegaly and variceal bleeding in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Liver disease as risk factor for cystic fibrosis-related diabetes development

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Transplantation for cystic fibrosis: outcome following early liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Effects of liver transplantation on the nutritional status of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

Hepatobiliary disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960006-4

7 January 2021

10.1016/S1569-1993(11)60006-4

Identifiers

DOI

1 reference

24 August 2017

1 reference